The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeting autophagy and immunotherapy with hydroxychloroquine and interleukin 2 in patients with metastatic renal cell carcinoma (mRCC): A Cytokine Working Group study.
 
Leonard Joseph Appleman
Research Funding - Acerta Pharma (Inst); Agensys (Inst); Astellas Pharma (Inst); AVEO (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Dendreon (Inst); Exelixis (Inst); Genentech/Roche (Inst); Medivation/Astellas; Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Prometheus (Inst); Sotio (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer; Cerulean Pharma; Exelixis
 
Theodore F. Logan
Consulting or Advisory Role - Prometheus
Research Funding - Abbott Laboratories (Inst); Abraxis BioScience (Inst); Acceleron Pharma (Inst); Amgen (Inst); Argos Therapeutics (Inst); AstraZeneca (Inst); AVEO (Inst); BioVex (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Eisai (Inst); EMD Serono (Inst); GlaxoSmithKline (Inst); immatics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Prometheus (Inst); Roche (Inst); Roche (Inst); Synta (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst)
 
Daniel Paul Normolle
Honoraria - NewLink Genetics
 
Marc S. Ernstoff
Stock and Other Ownership Interests - GE Healthcare
Consulting or Advisory Role - Bristol-Myers Squibb; Celyad; Lion Biotechnologies; Omniseq
Research Funding - Alkermes (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Merrimack (Inst)
 
Rahul Atul Parikh
Stock and Other Ownership Interests - Gilead Sciences (I)
Consulting or Advisory Role - Bayer
Research Funding - Saladax Biomedical
 
David F. McDermott
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; exelixis; Genentech/Roche; Merck; Novartis; Pfizer; X4 Pharma
Research Funding - Prometheus (Inst)
 
Paul Monk
Consulting or Advisory Role - Bayer; Lilly
Speakers' Bureau - Dendreon; Sanofi
Research Funding - Prometheus
Travel, Accommodations, Expenses - Lilly
 
Thomas Olencki
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); TRACON Pharma (Inst)
 
David Friedland
No Relationships to Disclose
 
Jodi Kathleen Maranchie
No Relationships to Disclose
 
Lisa Helene Butterfield
Stock and Other Ownership Interests - Kite, a Gilead company
Consulting or Advisory Role - Affymetrix; AstraZeneca; Immune Design; Kite, a Gilead company; Merck; Shire; Simpatica; Stericycle; Verastem
Patents, Royalties, Other Intellectual Property - Alpha Fetoprotein as an antigen for T cell responses in hepatocellular cancer
 
Xiaoyan Liang
Research Funding - Celgene; Cellular Therapeutics; Intezyne Technologies
Travel, Accommodations, Expenses - Torii Pharmaceutical
 
Michael T. Lotze
Employment - Lion Biotechnologies
Stock and Other Ownership Interests - Iovance Biotherapeutics
Consulting or Advisory Role - Celgene; Checkmate Pharmaceuticals; Pieris Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Patent distribution from Intrexon through University of Pittsburgh